责任编辑：小浪快报 截至9月30日，华大智造股东户数1.54万，较上期增加14.17%；人均流通股26794股，较上期增加 69.94%。2025年1月-9月，华大智造实现营业收入18.69亿元，同比减少0.01%；归母净利润-1.20亿元， 同比增长74.20%。 分红方面，华大智造A股上市后累计派现1.50亿元。 机构持仓方面，截止2025年9月30日，华大智造十大流通股东中，易方达上证科创板50ETF（588080） 位居第七大流通股东，持股752.58万股，相比上期减少109.79万股。华夏上证科创板50成份ETF （588000）位居第八大流通股东，持股734.95万股，相比上期减少418.28万股。华宝中证医疗ETF （512170）位居第十大流通股东，持股581.97万股，相比上期减少122.02万股。南方中证500ETF （510500）、香港中央结算有限公司退出十大流通股东之列。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.co ...

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 一、项目编号： SZT2025-NX-SC-ZC-HW-0950 采购计划编号 ： 2025NCZ004984 二、项目名称： 宁夏大学教学科研仪器设备更新项目（二期）十二 三、中标（成交）信息 | 供应商 | 供应商 | 供应商 | 中标（成 | | --- | --- | --- | --- | | 名称 | 地址 | 交） 联系电话 | | | | | 金额(元) | | | 宁夏石安电子科技有限 | 宁夏银川市金凤区宝湖福邸1号商住楼 | 138****3634 6698500.00 | | | 公司 | 1716室 | | | 四、 主要标 的信息 货物类 | 标的名 | 品牌 | 规格型号 | 数 | 总价(元) | 制 造 | | --- | --- | --- | --- | --- | --- | | 称 | | | 量 | | 商 | | 宁夏大 | | Amersham ImageQuant | | | | | 学教学 | Cytiva/Roche/力 | 800/Li ...

1月29日，华大智造涨5%，截至发稿，报69.30元/股，成交1.45亿元，换手率0.51%，总市值288.65亿 元。 资料显示，深圳华大智造科技股份有限公司位于广东省深圳市盐田区北山工业区综合楼及11栋2楼，成 立日期2016年4月13日，上市日期2022年9月9日，公司主营业务涉及专注于生命科学与生物技术领域,以 仪器设备、试剂耗材等相关产品的研发、生产和销售。主营业务收入构成为：销售仪器设备、试剂及耗 材90.89%，提供服务7.10%，其他(补充)2.01%。 从华大智造十大流通股东角度 数据显示，易方达基金旗下1只基金位居华大智造十大流通股东。易方达上证科创板50ETF（588080） 三季度减持109.79万股，持有股数752.58万股，占流通股的比例为1.82%。根据测算，今日浮盈赚取约 2483.52万元。 易方达上证科创板50ETF（588080）基金经理为林伟斌、成曦。 截至发稿，林伟斌累计任职时间12年333天，现任基金资产总规模1194.08亿元，任职期间最佳基金回报 82.52%， 任职期间最差基金回报-22.14%。 成曦累计任职时间9年270天，现任基金资产总规模2369.54 ...

华大智造表示，报告期内，公司制定了一系列"提质增效重回报"措施，包括人效提升、研发聚焦、营销 费用全周期管理等措施，导致公司相关的成本费用相比同期减少。报告期内，由于汇率波动，导致公司 持有外币货币性项目产生的汇兑收益同比增加。此外，报告期内，上半年对以前年度涉及的不确定性的 税务争议风险相应的税务拨备进行冲回处理，导致所得税费用同比减少。根据企业会计准则及公司会计 政策等相关规定，基于谨慎性原则，公司对截至2025年12月31日合并报表范围内的各类资产计提了减值 准备的会计处理。 北京商报讯（记者 丁宁）1月25日晚间，华大智造（688114）发布2025年业绩预告显示，公司经初步测 算，预计2025年实现归属净利润与上年同期相比，实现归属净利润-2.21亿元到-2.73亿元，同比减亏3.28 亿元到3.8亿元，同比亏损减少54.56%到63.22%。 资料显示，华大智造专注于生命科学与生物技术领域仪器设备、试剂耗材等相关产品的研发、生产和销 售。2025年，公司把握生命科技多组学融合与AI深度赋能的双重浪潮，并推动公司在生命科学领域的 持续发展，将原基因测序仪业务、实验室自动化业务及新业务板块，整合为三大 ...

Core Viewpoint - In 2026, the State Administration for Market Regulation will fully promote the implementation of domestic verification and evaluation work for inspection and testing instruments and equipment, focusing on three main areas [1] Group 1 - The establishment of an authoritative verification and evaluation standard system will be market demand-oriented, particularly developing a series of verification and evaluation standards for domestic instruments and equipment in the automotive and food sectors [1] - The initiative aims to tackle "bottleneck" core key technologies, focusing on high-end general equipment such as tire coupling road simulation testing machines to enhance the reliability and stability of domestic testing instruments and equipment [1] - The program will also cultivate brands with international competitiveness [1]

长城消费增值混合A（200006）成立日期2006年4月6日，最新规模5.16亿。今年以来收益22.7%，同类 排名65/8836；近一年收益49.42%，同类排名2496/8091；成立以来收益318.65%。 1月13日，华大智造涨5.08%，截至发稿，报82.78元/股，成交3.97亿元，换手率1.19%，总市值344.79亿 元。华大智造股价已经连续3天上涨，区间累计涨幅15.85%。 资料显示，深圳华大智造科技股份有限公司位于广东省深圳市盐田区北山工业区综合楼及11栋2楼，成 立日期2016年4月13日，上市日期2022年9月9日，公司主营业务涉及专注于生命科学与生物技术领域,以 仪器设备、试剂耗材等相关产品的研发、生产和销售。主营业务收入构成为：销售仪器设备、试剂及耗 材90.89%，提供服务7.10%，其他(补充)2.01%。 从基金十大重仓股角度 数据显示，长城基金旗下1只基金重仓华大智造。长城消费增值混合A（200006）三季度减持30万股， 持有股数93.2万股，占基金净值比例为7.65%，位居第四大重仓股。根据测算，今日浮盈赚取约372.8万 元。连续3天上涨期间浮盈赚取1004.69万 ...

据了解，中科仪主营业务为干式真空泵和真空科学仪器设备的研发、生产、销售，及相关技术服务。公 司IPO于2025年6月30日获得受理，当年7月24日进入问询阶段。 本次冲击上市，中科仪拟募集资金约8.25亿元，拟投资项目为干式真空泵产业化建设项目、高端半导体 设备扩产及研发中心建设项目、新一代干式真空泵及大抽速干式螺杆泵研发项目。 北京商报讯（记者 马换换 王蔓蕾）根据安排，中国科学院沈阳科学仪器股份有限公司（以下简称"中科 仪"）北交所IPO将于1月16日上会迎考。 ...

Group 1 - The core viewpoint of the news is that BGI Genomics has seen a stock price increase of 5.13%, reaching 63.88 CNY per share, with a total market capitalization of 26.607 billion CNY as of the report date [1] - BGI Genomics, established on April 13, 2016, and listed on September 9, 2022, focuses on the life sciences and biotechnology sectors, with 90.89% of its revenue coming from the sales of instruments, reagents, and consumables [1] - The company has a revenue composition of 90.89% from sales of instruments and consumables, 7.10% from services, and 2.01% from other sources [1] Group 2 - From the perspective of fund holdings, Guolian Fund has a significant position in BGI Genomics, with its Guolian Medical Health Mixed A fund holding 40,500 shares, representing 9.25% of the fund's net value [2] - The Guolian Medical Health Mixed A fund has a total scale of 8.3061 million CNY and has achieved a year-to-date return of 11.44%, ranking 5616 out of 8155 in its category [2] - The fund has a cumulative return of 25.67% since its inception on September 19, 2018 [2] Group 3 - The fund manager of Guolian Medical Health Mixed A is Liu Baichuan, who has been in the position for 345 days, managing assets totaling 30.2729 million CNY [3] - During Liu Baichuan's tenure, the best fund return was 14.38%, while the worst was 14.12% [3]

Core Insights - The Chinese Academy of Sciences Microelectronics Research Institute has announced three procurement intentions for instruments and equipment, with a total budget of 116 million yuan [1][2]. Procurement Details - The procurement includes: - A 12-inch high aspect ratio silicon oxide filling chemical vapor deposition system, budgeted at 52.6 million yuan, intended for advanced logic three-dimensional device shallow trench isolation filling, with a uniformity of less than 1.5% across the wafer [4]. - Lithography overlay accuracy measurement equipment (IBO), budgeted at 31 million yuan, which measures overlay errors with an accuracy of less than 0.15 nm and a measurement time of less than 0.3 seconds [4]. - Lithography overlay accuracy measurement equipment (DBO), budgeted at 32 million yuan, which measures overlay deviations with a total uncertainty of less than 0.2 nm and supports continuous wavelength measurement from 425 to 885 nanometers [4]. Timeline - The expected procurement time is set for November to December 2025 [2].

Core Insights - The article discusses the recent announcement by zycgr regarding 14 procurement intentions for scientific instruments, with a total budget of 396 million yuan [2][3]. Procurement Overview - The procurement includes various advanced instruments such as inductively coupled plasma etching machines, non-destructive global film thickness testing systems, multi-chamber deep silicon etching machines, and high-vacuum high-speed deposition systems [3][4]. - The expected procurement date is set for December 2025 [3]. Detailed Procurement List - The procurement list includes: - Dilution refrigerator: 700,000 yuan, requiring at least one year of warranty and lifetime technical support [5]. - Arbitrary waveform generator: 1.1 million yuan, with specifications including 4-channel output and a sampling rate of 10 GSa/s [5]. - High-vacuum high-speed deposition system: 2 million yuan, with a vacuum requirement of less than 5e-8 Torr [5]. - Inductively coupled plasma etching machine: 46.16 million yuan, for etching ion traps and quantum materials [5]. - Non-destructive global film thickness testing system: 1.5 million yuan, for testing film thickness distribution on 12-inch wafers [6]. - Multi-chamber deep silicon etching machine: 18 million yuan, for advanced packaging TSV hole etching [6]. - Fully automatic uniform coating and developing system: 32 million yuan, for automated coating and developing processes [6]. - Automated robot wafer transfer and workflow monitoring system: 100 million yuan, aimed at improving process efficiency [6]. - Ultra-stable lasers and other specialized laser systems with various specifications and budgets ranging from 143,000 to 238,000 yuan [6]. Conclusion - The procurement intentions reflect a significant investment in advanced scientific instruments, indicating a focus on enhancing research capabilities and technological advancements in the relevant fields [2][3].